Retina
Retinal Ganglion Cells
Photoreceptor Cells, Vertebrate
Photoreceptor Cells
Retinal Degeneration
Retinal Cone Photoreceptor Cells
Amacrine Cells
Retinal Rod Photoreceptor Cells
Pigment Epithelium of Eye
Dark Adaptation
Fluorescent Antibody Technique, Indirect
Rod Opsins
Retinal Bipolar Cells
Retinal Neurons
Eye
Choroid
Vitreous Body
Vision, Ocular
Retinal Horizontal Cells
Retinal Pigment Epithelium
Rhodopsin
Retinal Pigments
Neuroglia
Retinal Detachment
Retinal Neovascularization
Opsins
Diabetic Retinopathy
Adaptation, Ocular
Visual Pathways
Photic Stimulation
Rod Cell Outer Segment
Blood-Retinal Barrier
Chick Embryo
In Situ Hybridization
Retinitis Pigmentosa
Ambystoma
Immunohistochemistry
Fundus Oculi
Retinitis
Urodela
Fluorescein Angiography
Cell Count
RNA, Messenger
Glial Fibrillary Acidic Protein
Gene Expression Regulation, Developmental
Radiation Injuries, Experimental
Neurons
Zebrafish
Disease Models, Animal
Microscopy, Confocal
Reverse Transcriptase Polymerase Chain Reaction
Immunoenzyme Techniques
Superior Colliculi
Recoverin
Macula Lutea
Retinopathy of Prematurity
In Situ Nick-End Labeling
Fovea Centralis
Ciliary Body
Arrestin
Blotting, Western
Aminobutyrates
Retinal Photoreceptor Cell Outer Segment
Macular Degeneration
Ion-Selective Electrodes
Rabbits
Perches
Macaca fascicularis
Glaucoma
S100 Calcium Binding Protein G
Lens, Crystalline
Retinal Dysplasia
Tomography, Optical Coherence
Cats
Cone Opsins
Albinism
Receptors, GABA
Mice, Knockout
Rats, Sprague-Dawley
Visual Fields
Dendrites
Optic Disk
Cell Differentiation
Rats, Long-Evans
Pineal Gland
oko meduzy mutations affect neuronal patterning in the zebrafish retina and reveal cell-cell interactions of the retinal neuroepithelial sheet. (1/12697)
Mutations of the oko meduzy (ome) locus cause drastic neuronal patterning defect in the zebrafish retina. The precise, stratified appearance of the wild-type retina is absent in the mutants. Despite the lack of lamination, at least seven retinal cell types differentiate in oko meduzy. The ome phenotype is already expressed in the retinal neuroepithelium affecting morphology of the neuroepithelial cells. Our experiments indicate that previously unknown cell-cell interactions are involved in development of the retinal neuroepithelial sheet. In genetically mosaic animals, cell-cell interactions are sufficient to rescue the phenotype of oko meduzy retinal neuroepithelial cells. These cell-cell interactions may play a critical role in the patterning events that lead to differentiation of distinct neuronal laminae in the vertebrate retina. (+info)The cytoskeletal network controls c-Jun expression and glucocorticoid receptor transcriptional activity in an antagonistic and cell-type-specific manner. (2/12697)
The physical and functional link between adhesion molecules and the cytoskeletal network suggests that the cytoskeleton might mediate the transduction of cell-to-cell contact signals, which often regulate growth and differentiation in an antagonistic manner. Depolymerization of the cytoskeleton in confluent cell cultures is reportedly sufficient to initiate DNA synthesis. Here we show that depolymerization of the cytoskeleton is also sufficient to repress differentiation-specific gene expression. Glutamine synthetase is a glia-specific differentiation marker gene whose expression in the retinal tissue is regulated by glucocorticoids and is ultimately dependent on glia-neuron cell contacts. Depolymerization of the actin or microtubule network in cells of the intact retina mimics the effects of cell separation, repressing glutamine synthetase induction by a mechanism that involves induction of c-Jun and inhibition of glucocorticoid receptor transcriptional activity. Depolymerization of the cytoskeleton activates JNK and p38 mitogen-activated protein kinase and induces c-Jun expression by a signaling pathway that depends on tyrosine kinase activity. Induction of c-Jun expression is restricted to Muller glial cells, the only cells in the tissue that express glutamine synthetase and maintain the ability to proliferate upon cell separation. Our results suggest that the cytoskeletal network might play a part in the transduction of cell contact signals to the nucleus. (+info)Identification of a novel family of targets of PYK2 related to Drosophila retinal degeneration B (rdgB) protein. (3/12697)
The protein tyrosine kinase PYK2 has been implicated in signaling pathways activated by G-protein-coupled receptors, intracellular calcium, and stress signals. Here we describe the molecular cloning and characterization of a novel family of PYK2-binding proteins designated Nirs (PYK2 N-terminal domain-interacting receptors). The three Nir proteins (Nir1, Nir2, and Nir3) bind to the amino-terminal domain of PYK2 via a conserved sequence motif located in the carboxy terminus. The primary structures of Nirs reveal six putative transmembrane domains, a region homologous to phosphatidylinositol (PI) transfer protein, and an acidic domain. The Nir proteins are the human homologues of the Drosophila retinal degeneration B protein (rdgB), a protein implicated in the visual transduction pathway in flies. We demonstrate that Nirs are calcium-binding proteins that exhibit PI transfer activity in vivo. Activation of PYK2 by agents that elevate intracellular calcium or by phorbol ester induce tyrosine phosphorylation of Nirs. Moreover, PYK2 and Nirs exhibit similar expression patterns in several regions of the brain and retina. In addition, PYK2-Nir complexes are detected in lysates prepared from cultured cells or from brain tissues. Finally, the Nir1-encoding gene is located at human chromosome 17p13.1, in proximity to a locus responsible for several human retinal diseases. We propose that the Nir and rdgB proteins represent a new family of evolutionarily conserved PYK2-binding proteins that play a role in the control of calcium and phosphoinositide metabolism downstream of G-protein-coupled receptors. (+info)Involvement of poly (ADP-ribose)-polymerase in the Pax-6 gene regulation in neuroretina. (4/12697)
The quail Pax-6 gene is expressed from two promoters named P0 and P1. P0 promoter is under the control of a neuroretina-specific enhancer (EP). This enhancer activates the P0 promoter specifically in neuroretina cells and in a developmental stage-dependent manner. The EP enhancer binds efficiently, as revealed by southwestern experiments, to a 110 kDa protein present in neuroretina cells but not in Quail Embryos Cells and Retinal Pigmented Epithelium which do not express the P0-initiated mRNAs. To study the role of p110 in Pax-6 regulation, we have purified the p110 from neuroretina cells extracts. Based on the peptide sequence of the purified protein, we have identified the p110 as the poly(ADP-ribose) polymerase (PARP). Using bandshift experiments and footprinting studies, we present evidence that PARP is a component of protein complexes bound to the EP enhancer that increases the on rate of the protein complex formation to DNA. Using PARP inhibitors (3AB and 6.5 Hphe), we show that these products are able to inhibit EP enhancer activity in neuroretina cells. Finally, we demonstrate that these inhibitors are able to decrease the expression of the P0-initiated mRNA in the MC29-infected RPE cells which, in contrast to the RPE cells, accumulated the PARP in response to v-myc expression. Our results suggest that PARP is involved in the Pax-6 regulation. (+info)Cloning of a bovine orphan transporter and its short splicing variant. (5/12697)
We have isolated a cDNA (bv7-3) encoding a member of the Na+,Cl(-)-dependent transporter family and its short splicing variant (bv7-3s) by screening a bovine retina cDNA library. Sequence analysis revealed that bv7-3 encodes a protein of 729 amino acids and is a bovine homologue of the rat orphan transporter v7-3-2. bv7-3s contains 265 amino acids, sharing 252 N-terminal amino acids with bv7-3. Both mRNAs for bv7-3 and bv7-3s were detected in nervous system by Northern blot analysis. In immunofluorescence analysis in transfected HEK 293T cells, myc-tagged bv7-3 was mainly detected on the plasma membrane, whereas myc-tagged bv7-3s showed a pattern of intracellular membrane staining. (+info)Cell junctions in the developing compound eye of the desert locust Schistocerca gregaria. (6/12697)
Intercellular junctions in the developing retina of the locust Schistocerca gregaria have been examined by electron microscopy. Different types of junction appear in a well defined sequence during development. Five stages of ommatidial development are described. Close junctions and punctate junctions are present throughout development. Gap junctions appear transiently amongst the undifferentiated cells, before clearly defined preommatidia can be distinguished. The subsequent disappearance of gap junctions may be correlated with cell determination. Lanthanum studies confirm these findings. The later sequential appearance of adhesive junction types is described. These include septate desmosomes and two types of desmosomes. In the fully differentiated ommatidium only two types of junction remain, these are: desmosomes and rhabdomeric junctions. (+info)The neuronal basis of a sensory analyser, the acridid movement detector system. I. Effects of simple incremental and decremental stimuli in light and dark adapted animals. (7/12697)
1. The response of the movement detector (MD) system to proportionally constant incremental and decremental stimuli has been studied at various degrees of light and dark adaptation. Action potentials in the descending contralateral movement detector neurone were taken as the indicator of response. 2. Over a range of at least six log10 units of adapting luminance, the MD system behaves as an ON/OFF unit, giving responses to both incremental and decremental changes in the illumination of a 5 degrees target. 3. With increasing amplitudes of stimuli, both the ON and OFF responses saturate rapidly. Saturation is reached sooner at higher levels of light adaptation. At all levels of light adaptation, the OFF response is greater than the ON. The ratio for saturating stimuli is approximately constant at around 3:2. 4. At the brightest adapting luminances used (20 000 cd/m2) the ON response is reduced but not lost. At the lowest (0-004 cd/m2) the OFF response to a 5 degrees disc fails, but can be regained by increasing the test area to 10 degrees. 5. From what is known of the retina of locusts and other insects, it is thought that light and dark adaptation in the MD system can be adequately explained by events at the retinula cell. (+info)Light-induced calcium influx into retinal axons is regulated by presynaptic nicotinic acetylcholine receptor activity in vivo. (8/12697)
Visual activity is thought to be a critical factor in controlling the development of central retinal projections. Neuronal activity increases cytosolic calcium, which was hypothesized to regulate process outgrowth in neurons. We performed an in vivo imaging study in the retinotectal system of albino Xenopus laevis tadpoles with the fluorescent calcium indicator calcium green 1 dextran (CaGD) to test the role of calcium in regulating axon arbor development. We find that visual stimulus to the retina increased CaGD fluorescence intensity in retinal ganglion cell (RGC) axon arbors within the optic tectum and that branch additions to retinotectal axon arbors correlated with a local rise in calcium in the parent branch. We find three types of responses to visual stimulus, which roughly correlate with the ON, OFF, and SUSTAINED response types of RGC reported by physiological criteria. Imaging in bandscan mode indicated that patterns of calcium transients were nonuniform throughout the axons. We tested whether the increase in calcium in the retinotectal axons required synaptic activity in the retina; intraocular application of tetrodotoxin (10 microM) or nifedipine (1 and 10 microM) blocked the stimulus-induced increase in RGC axonal fluorescence. A second series of pharmacological investigations was designed to determine the mechanism of the calcium elevation in the axon terminals within the optic tectum. Injection of bis-(o-aminophenoxy)-N,N,N',N'-tetraacetic acid-AM (BAPTA-AM) (20 mM) into the tectal ventricle reduced axonal calcium levels, supporting the idea that visual stimulation increases axonal calcium. Injection of BAPTA (20 mM) into the tectal ventricle to chelate extracellular calcium also attenuated the calcium response to visual stimulation, indicating that calcium enters the axon from the extracellular medium. Caffeine (10 mM) caused a large increase in axonal calcium, indicating that intracellular stores contribute to the calcium signal. Presynaptic nicotinic acetylcholine receptors (nAChRs) may play a role in axon arbor development and the formation of the topographic retinotectal projection. Injection of nicotine (10 microM) into the tectal ventricle significantly elevated RGC axonal calcium levels, whereas application of the nAChR antagonist alphaBTX (100 nM) reduced the stimulus-evoked rise in RGC calcium fluorescence. These data suggest that light stimulus to the retina increases calcium in the axon terminal arbors through a mechanism that includes influx through nAChRs and amplification by calcium-induced calcium release from intracellular calcium stores. Such a mechanism may contribute to developmental plasticity of the retinotectal system by influencing both axon arbor elaboration and the strength of synaptic transmission. (+info)There are many different types of retinal degeneration, each with its own set of symptoms and causes. Some common forms of retinal degeneration include:
1. Age-related macular degeneration (AMD): This is the most common form of retinal degeneration and affects the macula, the part of the retina responsible for central vision. AMD can cause blind spots or distorted vision.
2. Retinitis pigmentosa (RP): This is a group of inherited conditions that affect the retina and can lead to night blindness, loss of peripheral vision, and eventually complete vision loss.
3. Leber congenital amaurosis (LCA): This is a rare inherited condition that causes severe vision loss or blindness at birth or within the first few years of life.
4. Stargardt disease: This is a rare inherited condition that causes progressive vision loss and can lead to blindness.
5. Retinal detachment: This occurs when the retina becomes separated from the underlying tissue, causing vision loss.
6. Diabetic retinopathy (DR): This is a complication of diabetes that can cause damage to the blood vessels in the retina and lead to vision loss.
7. Retinal vein occlusion (RVO): This occurs when a blockage forms in the small veins that carry blood away from the retina, causing vision loss.
There are several risk factors for retinal degeneration, including:
1. Age: Many forms of retinal degeneration are age-related and become more common as people get older.
2. Family history: Inherited conditions such as RP and LCA can increase the risk of retinal degeneration.
3. Genetics: Some forms of retinal degeneration are caused by genetic mutations.
4. Diabetes: Diabetes is a major risk factor for diabetic retinopathy, which can cause vision loss.
5. Hypertension: High blood pressure can increase the risk of retinal vein occlusion and other forms of retinal degeneration.
6. Smoking: Smoking has been linked to an increased risk of several forms of retinal degeneration.
7. UV exposure: Prolonged exposure to UV radiation from sunlight can increase the risk of retinal degeneration.
There are several treatment options for retinal degeneration, including:
1. Vitamin and mineral supplements: Vitamins A, C, and E, as well as zinc and selenium, have been shown to slow the progression of certain forms of retinal degeneration.
2. Anti-vascular endothelial growth factor (VEGF) injections: These medications can help reduce swelling and slow the progression of diabetic retinopathy and other forms of retinal degeneration.
3. Photodynamic therapy: This involves the use of a light-sensitive medication and low-intensity laser light to damage and shrink abnormal blood vessels in the retina.
4. Retinal implants: These devices can be used to restore some vision in people with advanced forms of retinal degeneration.
5. Stem cell therapy: Research is ongoing into the use of stem cells to repair damaged retinal cells and restore vision.
It's important to note that early detection and treatment of retinal degeneration can help to slow or stop the progression of the disease, preserving vision for as long as possible. Regular eye exams are crucial for detecting retinal degeneration in its early stages, when treatment is most effective.
Examples of retinal diseases include:
1. Age-related macular degeneration (AMD): a leading cause of vision loss in people over the age of 50, AMD affects the macula, the part of the retina responsible for central vision.
2. Diabetic retinopathy (DR): a complication of diabetes that damages blood vessels in the retina and can cause blindness.
3. Retinal detachment: a condition where the retina becomes separated from the underlying tissue, causing vision loss.
4. Macular edema: swelling of the macula that can cause vision loss.
5. Retinal vein occlusion (RVO): a blockage of the small veins in the retina that can cause vision loss.
6. Retinitis pigmentosa (RP): a group of inherited disorders that affect the retina and can cause progressive vision loss.
7. Leber congenital amaurosis (LCA): an inherited disorder that causes blindness or severe visual impairment at birth or in early childhood.
8. Stargardt disease: a rare inherited disorder that affects the retina and can cause progressive vision loss, usually starting in childhood.
9. Juvenile macular degeneration: a rare inherited disorder that causes vision loss in young adults.
10. Retinal dystrophy: a group of inherited disorders that affect the retina and can cause progressive vision loss.
Retinal diseases can be diagnosed with a comprehensive eye exam, which includes a visual acuity test, dilated eye exam, and imaging tests such as optical coherence tomography (OCT) or fluorescein angiography. Treatment options vary depending on the specific disease and can include medication, laser surgery, or vitrectomy.
It's important to note that many retinal diseases can be inherited, so if you have a family history of eye problems, it's important to discuss your risk factors with your eye doctor. Early detection and treatment can help preserve vision and improve quality of life for those affected by these diseases.
The retina is a layer of cells that lines the inside of the eye and senses light to send visual signals to the brain. When the retina becomes detached, it can no longer function properly, leading to vision loss or distortion.
Retinal detachment can be caused by a variety of factors, including:
1. Age-related changes: As we age, the vitreous gel that fills the eye can become more liquid and pull away from the retina, causing a retinal detachment.
2. Injury or trauma: A blow to the head or a penetrating injury can cause a retinal detachment.
3. Medical conditions: Certain conditions, such as diabetes, high blood pressure, and sickle cell disease, can increase the risk of developing a retinal detachment.
4. Genetic factors: Some people may be more prone to developing a retinal detachment due to inherited genetic factors.
Symptoms of retinal detachment may include:
1. Flashes of light: People may see flashes of light in the peripheral vision.
2. Floaters: Specks or cobwebs may appear in the vision, particularly in the periphery.
3. Blurred vision: Blurred vision or distorted vision may occur as the retina becomes detached.
4. Loss of vision: In severe cases, a retinal detachment can cause a complete loss of vision in one eye.
If you experience any of these symptoms, it is important to seek medical attention immediately. A comprehensive eye exam can diagnose a retinal detachment and determine the appropriate treatment.
Treatment for retinal detachment typically involves surgery to reattach the retina to the underlying tissue. In some cases, laser surgery may be used to seal off any tears or holes in the retina that caused the detachment. In more severe cases, a scleral buckle or other device may be implanted to support the retina and prevent further detachment.
In addition to surgical treatment, there are some lifestyle changes you can make to help reduce your risk of developing a retinal detachment:
1. Quit smoking: Smoking has been linked to an increased risk of retinal detachment. Quitting smoking can help reduce this risk.
2. Maintain a healthy blood pressure: High blood pressure can increase the risk of retinal detachment. Monitoring and controlling your blood pressure can help reduce this risk.
3. Wear protective eyewear: If you participate in activities that could potentially cause eye injury, such as sports or working with hazardous materials, wearing protective eyewear can help reduce the risk of retinal detachment.
4. Get regular eye exams: Regular comprehensive eye exams can help detect any potential issues with the retina before they become serious problems.
Overall, a retinal detachment is a serious condition that requires prompt medical attention to prevent long-term vision loss. By understanding the causes and symptoms of retinal detachment, as well as making lifestyle changes to reduce your risk, you can help protect your vision and maintain good eye health.
The growth of new blood vessels in the retina is a natural response to hypoxia (lack of oxygen) and inflammation caused by these diseases. However, these new blood vessels are fragile and can cause damage to the retina, leading to vision loss. In some cases, RNV can also lead to vitreous hemorrhage, retinal detachment, or glaucoma, which can further exacerbate vision loss.
The diagnosis of RNV is typically made through a comprehensive eye exam, including a visual acuity test, dilated eye exam, and imaging tests such as fluorescein angiography or optical coherence tomography (OCT). Treatment options for RNV depend on the underlying cause of the condition and may include medications, laser therapy, or vitrectomy.
In summary, retinal neovascularization is a common complication of various retinal diseases that can lead to vision loss if left untreated. Early detection and prompt treatment are essential to prevent further damage and preserve visual function.
There are two main types of DR:
1. Non-proliferative diabetic retinopathy (NPDR): This is the early stage of DR, where the blood vessels in the retina become damaged and start to leak fluid or bleed. The symptoms can be mild or severe and may include blurred vision, floaters, and flashes of light.
2. Proliferative diabetic retinopathy (PDR): This is the advanced stage of DR, where new blood vessels start to grow in the retina. These vessels are weak and can cause severe bleeding, leading to vision loss.
DR is a common complication of diabetes, and it is estimated that up to 80% of people with diabetes will develop some form of DR over their lifetime. The risk of developing DR increases with the duration of diabetes and the level of blood sugar control.
Early detection and treatment of DR can help to prevent vision loss, so it is important for people with diabetes to have regular eye exams to monitor their retinal health. Treatment options for DR include laser surgery, injections of anti-vascular endothelial growth factor (VEGF) medications, and vitrectomy, a surgical procedure to remove the vitreous gel and blood from the eye.
Preventing Diabetic Retinopathy
While there is no surefire way to prevent diabetic retinopathy (DR), there are several steps that people with diabetes can take to reduce their risk of developing this complication:
1. Control blood sugar levels: Keeping blood sugar levels within a healthy range can help to slow the progression of DR. This can be achieved through a combination of diet, exercise, and medication.
2. Monitor blood pressure: High blood pressure can damage the blood vessels in the retina, so it is important to monitor and control blood pressure to reduce the risk of DR.
3. Maintain healthy blood lipids: Elevated levels of low-density lipoprotein (LDL) cholesterol and lower levels of high-density lipoprotein (HDL) cholesterol can increase the risk of DR.
4. Quit smoking: Smoking can damage the blood vessels in the retina and increase the risk of DR.
5. Maintain a healthy weight: Obesity is a risk factor for DR, so maintaining a healthy weight can help to reduce the risk of this complication.
6. Get regular eye exams: Regular eye exams can help to detect DR in its early stages, when it is easier to treat and prevent vision loss.
Preventing Diabetic Retinopathy
While there is no cure for diabetic retinopathy (DR), there are several treatment options available to help manage the condition and prevent vision loss. These include:
1. Laser surgery: This is a common treatment for early-stage DR, where a laser is used to shrink abnormal blood vessels in the retina and reduce the risk of further damage.
2. Injection therapy: Medications such as anti-vascular endothelial growth factor (VEGF) injections can be used to shrink abnormal blood vessels and reduce swelling in the retina.
3. Vitrectomy: In severe cases of DR, a vitrectomy may be performed to remove scar tissue and blood from the center of the eye.
4. Blood pressure control: Maintaining healthy blood pressure can help to slow the progression of DR.
5. Blood glucose control: Keeping blood sugar levels under control can also slow the progression of DR.
6. Follow-up care: Regular follow-up appointments with an eye doctor are important to monitor the progress of DR and adjust treatment as needed.
Early detection and treatment of diabetic retinopathy can help to prevent vision loss and improve outcomes for individuals with this complication of diabetes. By managing blood sugar levels, blood pressure, and cholesterol, and by getting regular eye exams, individuals with diabetes can reduce their risk of developing DR and other diabetic complications.
The symptoms of RP can vary depending on the severity of the condition and the specific genetic mutations causing it. Common symptoms include:
* Night blindness
* Difficulty seeing in low light environments
* Blind spots or missing areas in central vision
* Difficulty reading or recognizing faces
* Sensitivity to light
* Reduced peripheral vision
* Blurred vision
There is currently no cure for RP, and treatment options are limited. However, researchers are actively working to develop new therapies and technologies to slow the progression of the disease and improve the quality of life for individuals with RP. These include:
* Gene therapy: Using viral vectors to deliver healthy copies of the missing gene to the retina in an effort to restore normal vision.
* Stem cell therapy: Transplanting healthy stem cells into the retina to replace damaged or missing cells.
* Pharmacological interventions: Developing drugs that can slow down or reverse the progression of RP by targeting specific molecular pathways.
* Retinal implants: Implanting a retinal implant, such as a retinal prosthetic, to bypass damaged or non-functional photoreceptors and directly stimulate the visual pathway.
It's important to note that these therapies are still in the experimental stage and have not yet been proven effective in humans. Therefore, individuals with RP should consult with their healthcare provider about the best treatment options available.
In summary, Retinitis Pigmentosa is a genetic disorder that causes progressive vision loss, particularly during childhood or adolescence. While there is currently no cure for RP, researchers are actively working to develop new therapies to slow down or restore vision in those affected by the disease. These include gene therapy, stem cell therapy, pharmacological interventions, and retinal implants. It's important to consult with a healthcare provider for the best treatment options available.
FAQs:
1. What is Retinitis Pigmentosa?
Retinitis Pigmentosa (RP) is a genetic disorder that causes progressive vision loss, typically during childhood or adolescence.
2. What are the symptoms of Retinitis Pigmentosa?
Symptoms of RP can vary depending on the specific mutation causing the disease, but common symptoms include difficulty seeing at night, loss of peripheral vision, and difficulty adjusting to bright light.
3. Is there a cure for Retinitis Pigmentosa?
Currently, there is no cure for RP, but researchers are actively working on developing new therapies to slow down or restore vision in those affected by the disease.
4. What are some potential treatments for Retinitis Pigmentosa?
Some potential treatments for RP include gene therapy, stem cell therapy, pharmacological interventions, and retinal implants. It's important to consult with a healthcare provider for the best treatment options available.
5. Can Retinitis Pigmentosa be prevented?
RP is a genetic disorder, so it cannot be prevented in the classical sense. However, researchers are working on developing gene therapies that can prevent or slow down the progression of the disease.
6. How does Retinitis Pigmentosa affect daily life?
Living with RP can significantly impact daily life, especially as vision loss progresses. It's important to adapt and modify daily routines, such as using assistive devices like canes or guide dogs, and seeking support from family and friends.
7. What resources are available for those affected by Retinitis Pigmentosa?
There are a variety of resources available for those affected by RP, including support groups, advocacy organizations, and online communities. These resources can provide valuable information, support, and connections with others who understand the challenges of living with the disease.
There are several types of retinitis, including:
1. Retinitis pigmentosa: This is a group of inherited conditions that cause progressive vision loss due to degeneration of the retina.
2. Cytomegalovirus (CMV) retinitis: This is a type of retinitis caused by the CMV virus, which is common in people with weakened immune systems, such as those with HIV/AIDS.
3. Toxoplasma retinitis: This is a type of retinitis caused by the Toxoplasma gondii parasite, which can cause vision loss if left untreated.
4. Syphilitic retinitis: This is a type of retinitis caused by the bacteria Treponema pallidum, which can cause vision loss if left untreated.
5. Uveitis-related retinitis: This is a type of retinitis that occurs as a complication of uveitis, an inflammation of the uvea, the middle layer of the eye.
Symptoms of retinitis can include vision loss, blurred vision, sensitivity to light, and floaters (specks or cobwebs in your vision). If you experience any of these symptoms, it is important to seek medical attention as soon as possible.
Retinitis is typically diagnosed through a combination of physical examination, imaging tests such as optical coherence tomography (OCT), and laboratory tests to identify the underlying cause. Treatment for retinitis depends on the underlying cause and may include antiviral or antibacterial medications, immunosuppressive drugs, or surgery. In some cases, vision loss may be permanent, but early diagnosis and treatment can help prevent further damage and improve outcomes.
Experimental radiation injuries are those that are intentionally caused in animal models or human subjects for research purposes, with the goal of understanding the effects of ionizing radiation on living organisms and developing treatments to mitigate these effects.
The study of experimental radiation injuries involves exposing animals or human subjects to varying levels of ionizing radiation and observing the resulting damage and recovery processes. This research has led to a better understanding of the mechanisms of radiation injury and the development of treatment strategies, such as blood transfusions and antioxidants, to mitigate the effects of radiation exposure.
Experimental radiation injuries are classified into two main types: acute and late-onset injuries. Acute radiation syndrome (ARS), also known as radiation sickness or radiation poisoning, occurs within hours to days after exposure and is characterized by nausea, vomiting, diarrhea, fatigue, and damage to the bone marrow, lungs, and gastrointestinal tract. Late-onset injuries, such as cancer and other chronic effects, can occur months or years after exposure and are caused by DNA damage and epigenetic changes.
Prevention of experimental radiation injuries is essential in reducing the risk of radiation exposure to humans and the environment. This includes using personal protective equipment, minimizing the use of ionizing radiation in medical procedures and research, and developing new technologies that reduce radiation exposure.
In summary, experimental radiation injuries are intentionally caused in animal models or human subjects for research purposes to understand the effects of ionizing radiation on living organisms and develop treatments to mitigate these effects. The study of experimental radiation injuries has led to a better understanding of the mechanisms of radiation injury and the development of treatment strategies, but prevention is essential in reducing the risk of radiation exposure.
There are many different types of uveal diseases, including:
1. Uveitis: This is inflammation of the uvea, which can be caused by a variety of factors such as infection, injury, or autoimmune disorders.
2. Iridocyclitis: This is inflammation of the iris and ciliary body.
3. Choroiditis: This is inflammation of the choroid layer of the uvea.
4. Retinal vein occlusion: This is a blockage of the veins that carry blood away from the retina, which can cause vision loss.
5. Macular edema: This is swelling of the macula, the part of the retina responsible for central vision.
6. Age-related macular degeneration (AMD): This is a condition that affects the macula and can cause vision loss over time.
7. Diabetic retinopathy: This is a complication of diabetes that can cause damage to the blood vessels in the retina and lead to vision loss.
8. Retinal detachment: This is a condition where the retina becomes separated from the underlying tissue, leading to vision loss.
9. Retinal vein thrombosis: This is a blockage of the veins that carry blood away from the retina, which can cause vision loss.
10. Uveal melanoma: This is a type of cancer that affects the uvea and can be potentially life-threatening.
These are just a few examples of uveal diseases, and there are many other conditions that can affect the uvea as well. Treatment options for uveal diseases vary depending on the specific condition and its cause, but may include medications, laser surgery, or other procedures to treat inflammation, reduce swelling, or remove tumors.
1) They share similarities with humans: Many animal species share similar biological and physiological characteristics with humans, making them useful for studying human diseases. For example, mice and rats are often used to study diseases such as diabetes, heart disease, and cancer because they have similar metabolic and cardiovascular systems to humans.
2) They can be genetically manipulated: Animal disease models can be genetically engineered to develop specific diseases or to model human genetic disorders. This allows researchers to study the progression of the disease and test potential treatments in a controlled environment.
3) They can be used to test drugs and therapies: Before new drugs or therapies are tested in humans, they are often first tested in animal models of disease. This allows researchers to assess the safety and efficacy of the treatment before moving on to human clinical trials.
4) They can provide insights into disease mechanisms: Studying disease models in animals can provide valuable insights into the underlying mechanisms of a particular disease. This information can then be used to develop new treatments or improve existing ones.
5) Reduces the need for human testing: Using animal disease models reduces the need for human testing, which can be time-consuming, expensive, and ethically challenging. However, it is important to note that animal models are not perfect substitutes for human subjects, and results obtained from animal studies may not always translate to humans.
6) They can be used to study infectious diseases: Animal disease models can be used to study infectious diseases such as HIV, TB, and malaria. These models allow researchers to understand how the disease is transmitted, how it progresses, and how it responds to treatment.
7) They can be used to study complex diseases: Animal disease models can be used to study complex diseases such as cancer, diabetes, and heart disease. These models allow researchers to understand the underlying mechanisms of the disease and test potential treatments.
8) They are cost-effective: Animal disease models are often less expensive than human clinical trials, making them a cost-effective way to conduct research.
9) They can be used to study drug delivery: Animal disease models can be used to study drug delivery and pharmacokinetics, which is important for developing new drugs and drug delivery systems.
10) They can be used to study aging: Animal disease models can be used to study the aging process and age-related diseases such as Alzheimer's and Parkinson's. This allows researchers to understand how aging contributes to disease and develop potential treatments.
The exact cause of ROP is not known, but it is thought to be related to the immaturity of the retina and the high levels of oxygen in incubators used to care for premature babies. The risk of developing ROP increases with the degree of prematurity, with infants born before 28 weeks gestation being at highest risk.
ROP typically develops in two stages:
1. Stage 1: Early ROP - This stage is characterized by the formation of small blood vessels and immature retinal tissue.
2. Stage 2: Advanced ROP - This stage is characterized by the proliferation of abnormal blood vessels, bleeding, and scarring in the retina.
There are several subtypes of ROP, including:
1. Type 1 ROP: Mildest form of the disease, with few or no complications.
2. Type 2 ROP: More severe form of the disease, with abnormal blood vessel growth and scarring in the retina.
3. Type 3 ROP: Most severe form of the disease, with widespread scarring and bleeding in the retina.
Treatment for ROP typically involves monitoring the infant's eye development closely and applying laser therapy to the affected areas if necessary. In severe cases, surgery may be required to remove abnormal blood vessels or scar tissue.
Prevention of ROP is primarily focused on reducing the risk factors, such as prematurity and oxygen exposure. This includes:
1. Proper management of gestational diabetes to prevent preterm birth.
2. Close monitoring of fetal development and early delivery if necessary.
3. Careful regulation of oxygen levels in incubators to avoid over-oxygenation.
4. Early detection and treatment of infections that can lead to preterm birth.
5. Avoiding excessive use of ophthalmic drugs that can be harmful to the developing retina.
Early detection and timely intervention are crucial for effective management and prevention of ROP. Regular eye exams and screening are necessary to identify the disease in its early stages, when treatment is most effective.
There are two main types of MD:
1. Dry Macular Degeneration (DMD): This is the most common form of MD, accounting for about 90% of cases. It is caused by the gradual accumulation of waste material in the macula, which can lead to cell death and vision loss over time.
2. Wet Macular Degeneration (WMD): This type of MD is less common but more aggressive, accounting for about 10% of cases. It occurs when new blood vessels grow underneath the retina, leaking fluid and causing damage to the macula. This can lead to rapid vision loss if left untreated.
The symptoms of MD can vary depending on the severity and type of the condition. Common symptoms include:
* Blurred vision
* Distorted vision (e.g., straight lines appearing wavy)
* Difficulty reading or recognizing faces
* Difficulty adjusting to bright light
* Blind spots in central vision
MD can have a significant impact on daily life, making it difficult to perform everyday tasks such as driving, reading, and recognizing faces.
There is currently no cure for MD, but there are several treatment options available to slow down the progression of the disease and manage its symptoms. These include:
* Anti-vascular endothelial growth factor (VEGF) injections: These medications can help prevent the growth of new blood vessels and reduce inflammation in the macula.
* Photodynamic therapy: This involves the use of a light-sensitive drug and low-intensity laser to damage and shrink the abnormal blood vessels in the macula.
* Vitamin supplements: Certain vitamins, such as vitamin C, E, and beta-carotene, have been shown to slow down the progression of MD.
* Laser surgery: This can be used to reduce the number of abnormal blood vessels in the macula and improve vision.
It is important for individuals with MD to receive regular monitoring and treatment from an eye care professional to manage their condition and prevent complications.
There are several different types of glaucoma, including:
* Open-angle glaucoma: This is the most common form of glaucoma, and is caused by slowed drainage of fluid from the eye.
* Closed-angle glaucoma: This type of glaucoma is caused by a blockage in the drainage channels of the eye, leading to a sudden increase in pressure.
* Normal-tension glaucoma: This type of glaucoma is caused by damage to the optic nerve even though the pressure in the eye is within the normal range.
* Congenital glaucoma: This is a rare type of glaucoma that is present at birth, and is caused by a developmental defect in the eye's drainage system.
Symptoms of glaucoma can include:
* Blurred vision
* Loss of peripheral vision
* Eye pain or pressure
* Redness of the eye
* Seeing halos around lights
Glaucoma is typically diagnosed with a combination of visual acuity tests, dilated eye exams, and imaging tests such as ultrasound or MRI. Treatment for glaucoma usually involves medication to reduce pressure in the eye, but may also include surgery to improve drainage or laser therapy to prevent further damage to the optic nerve.
Early detection and treatment of glaucoma is important to prevent vision loss, so it is important to have regular eye exams, especially if you are at risk for the condition. Risk factors for glaucoma include:
* Age (over 60)
* Family history of glaucoma
* Diabetes
* High blood pressure
* African or Hispanic ancestry
Overall, glaucoma is a serious eye condition that can cause vision loss if left untreated. Early detection and treatment are key to preventing vision loss and maintaining good eye health.
Types of Retinal Dysplasia:
1. Retinal dysplasia with macular involvement: This type affects the macula, the central part of the retina responsible for central vision. It can cause blurred vision, distorted vision, and difficulty reading or recognizing faces.
2. Retinal dysplasia without macular involvement: This type affects the peripheral retina and can cause peripheral vision loss.
3. Coloboma of the retina: This is a rare type of retinal dysplasia that affects the optic nerve and can cause blind spots in the visual field.
4. Retinal pigment epithelial dysplasia: This type affects the layer of cells underneath the retina and can cause vision problems or blindness.
Causes of Retinal Dysplasia:
1. Genetics: Many cases of retinal dysplasia are inherited, with genetic mutations passed down from parents to children.
2. Premature birth: Babies born prematurely are at a higher risk of developing retinal dysplasia.
3. Maternal infection during pregnancy: Certain infections, such as rubella or toxoplasmosis, can increase the risk of retinal dysplasia in the developing fetus.
4. Trauma: In some cases, retinal dysplasia may be caused by trauma to the eye during fetal development or early childhood.
Symptoms of Retinal Dysplasia:
1. Blurred vision
2. Distorted vision
3. Difficulty reading or recognizing faces
4. Peripheral vision loss
5. Blind spots in the visual field (in severe cases)
Diagnosis of Retinal Dysplasia:
1. Ophthalmological examination: An eye doctor will perform a comprehensive eye exam to assess vision and examine the retina using an ophthalmoscope or ultrasound.
2. Electrooculography (EOG): This test measures the electrical activity of the retina and can help identify any abnormalities.
3. Visual evoked potentials (VEP): This test measures the response of the retina to visual stimuli and can help identify any abnormalities.
4. Genetic testing: In some cases, genetic testing may be performed to identify genetic mutations associated with retinal dysplasia.
Treatment of Retinal Dysplasia:
1. Glasses or contact lenses: In mild cases, corrective lenses can help improve vision.
2. Vitamin A supplements: Vitamin A is essential for healthy retinal function, and deficiencies can exacerbate retinal dysplasia.
3. Laser therapy: Focal laser therapy can be used to reduce the size of lesions and improve vision.
4. Photodynamic therapy: This involves the use of a light-sensitive medication and low-intensity laser light to damage and shrink abnormal retinal tissue.
5. Retinal detachment surgery: In cases where retinal dysplasia has led to retinal detachment, surgery may be necessary to reattach the retina.
6. Vitrectomy: In severe cases of retinal dysplasia, a vitrectomy (removal of the vitreous gel) may be performed to relieve symptoms and improve vision.
It is important to note that the prognosis for retinal dysplasia can vary depending on the severity of the condition and the presence of any underlying conditions. In some cases, retinal dysplasia may resolve on its own over time, while in other cases, it may lead to permanent vision loss if left untreated. Regular follow-up appointments with an eye doctor are essential for monitoring the condition and determining the best course of treatment.
The most common symptoms of albinism include:
* Pale or white skin, hair, and eyes
* Sensitivity to the sun and risk of sunburn
* Poor vision, including nystagmus (involuntary eye movements) and photophobia (sensitivity to light)
* Increased risk of eye problems, such as strabismus (crossed eyes) and amblyopia (lazy eye)
* Increased risk of skin cancer and other skin problems
* Delayed development of motor skills and coordination
* Increased risk of infection and other health problems due to a weakened immune system
Albinism is caused by mutations in genes that code for enzymes involved in the production of melanin. These mutations can be inherited from one or both parents, or they can occur spontaneously. There is no cure for albinism, but there are treatments available to help manage some of the associated symptoms and vision problems.
Diagnosis of albinism is typically made based on a combination of physical examination, medical history, and genetic testing. Treatment may include sun protection measures, glasses or contact lenses to improve vision, and medication to manage eye problems. In some cases, surgery may be necessary to correct eye alignment or other physical abnormalities.
It's important for people with albinism to receive regular medical care and monitoring to ensure early detection and treatment of any associated health problems. With proper care and support, many people with albinism can lead normal, fulfilling lives.
Retina
Duplex retina
Plaid Retina
Retina display
Kodak Retina
Retina UK
Retina (typeface)
Retina (disambiguation)
Kodak Retina Reflex
Macula of retina
Retina horizontal cell
Retina bipolar cell
Retina-X Studios
Retina medical search
Ophthalmic Surgery, Lasers and Imaging Retina
Gene therapy of the human retina
Pars ciliaris retinae
Retina (or More Fun Than a Vat of Love)
Prostaglandin-endoperoxide synthase 2
Metamorphopsia
Carbonic anhydrase III, muscle specific
Light therapy
Pegaptanib
Michael Belkin (ophthalmologist)
Eales disease
Human eye
Vitreomacular adhesion
Glossary of diabetes
Retinoschisin
Geographic atrophy
Retina: MedlinePlus Medical Encyclopedia
Helping the retina regenerate | National Eye Institute
Gyrate atrophy of choroid and retina - About the Disease - Genetic and Rare Diseases Information Center
Greenwashing the Retina MacBook Pro | WIRED
MacBook Pro with retina display
Definition of Retina HD | PCMag
More Evidence for 2048x1536 iPad Retina Display - MacRumors
Detached Retina - American Academy of Ophthalmology
Apple Introduces 27-inch iMac with Retina 5K Display - Apple
ESCRS - Retina
iPhone 4 early shipments include some defective Retina displays | Engadget
RWD Cross-Fade Slideshow with Retina Images - Blogs - Dynamic Drive Forums
Envision - Responsive Retina Multi-Purpose Theme by orqun | ThemeForest
388+ Retina Ready PrestaShop Themes for Online Stores | TemplateMonster
Immune cell regeneration in mouse retina | National Institutes of Health (NIH)
Apple activates Quality Program for Retina MacBook Pro screen coating issue | AppleInsider
Apple Introduces iPad Pro Featuring Epic 12.9-inch Retina Display | Business Wire
Is Your Website Retina Display Ready? | Web Hosting Geeks' Blog
The Vergecast 022: Retina comes to iPad, network buildouts - The Verge
8GB Memory for 2011-2012 MacBook Pro (Non-Retina)
Light adaptation in luminosity horizontal cells in the turtle retina. Role of cellular coupling
Using Compass to generate normal and retina sprite maps at once · GitHub
apple-history.com / MacBook Pro (Retina, 13-inch, Early 2015)
CRITICAL EVALUATION OF THE USABILITY OF AUGMENTED REALITY OP... : RETINA
Apple unveils MacBook Pro with Retina display - Videoguys
MacBook Pro 15' Retina Mid 2015 Ports | iFixit
Retina MBPro wont boot. Ideas? | [H]ard|Forum
Rumor: iPad 3 Retina display analyzed by iFixIt
IPad9
- More evidence has emerged to suggest that a future version of the iPad will sport a "Retina" display with a resolution of 2048x1536, or double the horizontal and vertical pixels of the current iPad. (macrumors.com)
- Based on the discovery of pixel-doubled iPad images as far back as January , we are hesitant to attach any significant timeline to these discoveries, but they are simply more signs that Apple plans to release a Retina Display-equipped iPad. (macrumors.com)
- If Apple release a Retina iPad for the current $500/16GB, I'm sold! (macrumors.com)
- So the iPad 3 will come out around iOS 5 with Retina display Twitter functionality and normal everything else? (macrumors.com)
- At this point, if Apple announces anything less than a Retina display iPad with bumped specs and at least the same level of battery life, there is bound to be a huge groan-fest all over the Internet and Wall Street. (macgasm.net)
- What do you think about this supposed iPad 3 Retina display? (macgasm.net)
- According to EmertHacks , the LG part number for retina iPad screens is LP097QX1-SPA1. (pcper.com)
- SAN FRANCISCO - September 9, 2015 - Apple® today introduced the all-new iPad Pro™, featuring a stunning 12.9-inch Retina® display with 5.6 million pixels, the most ever in an iOS device, and groundbreaking performance with the new 64-bit A9X chip, rivaling most portable PCs. (telecomtv.com)
- Innovative Design iPad Pro's 12.9-inch Retina display, with 5.6 million pixels and refined Multi-Touch technology, is the most advanced and highest resolution display ever in an iOS device. (telecomtv.com)
MacBook Pro with Retina1
- Apple announced they were leaving the EPEAT registry soon after they released a slew of new laptops this summer, including the MacBook Pro with Retina display. (wired.com)
Retinal detachment1
- A retinal detachment lifts or pulls the retina from its normal position. (medlineplus.gov)
IPhone4
- This suggested a similar pixel-doubling strategy to that used in the iPhone 4's Retina Display. (macrumors.com)
- Several folks who've received an iPhone 4 early are tipping us and reporting to Apple that the fancy, new Retina displays on their new iPhones are defective and showing odd, colored splotches near the bottom edges of the screen. (engadget.com)
- All assets are selected with care so they look great on high pixel desnity devices like iPads, iPhone, Android Devices, Retina Mac Book etc. (themeforest.net)
- Today, Apple has published a new ad for its hottest selling gadget the, iPhone 4 which highlights its stunning high-resolution Retina display. (ithinkdiff.com)
20232
- Ophthalmol Retina;2023 Jul 28. (bvsalud.org)
- SEATTLE - Uveitis expert Nisha Acharya, MD, shared three clinical pearls on the condition at the American Society of Retina Specialists (ASRS) 2023 Annual Meeting. (medscape.com)
Display31
- See Retina Display . (pcmag.com)
- CUPERTINO, California-October 16, 2014-Apple® today unveiled the 27-inch iMac® with Retina® 5K display, featuring the world's highest resolution display with a breathtaking 14.7 million pixels. (apple.com)
- With the latest quad-core processors, high-performance graphics, Fusion Drive and Thunderbolt 2, iMac with Retina 5K display is the most powerful iMac ever made-it's the ultimate display combined with the ultimate all-in-one. (apple.com)
- Thirty years after the first Mac changed the world, the new iMac with Retina 5K display running OS X Yosemite is the most insanely great Mac we have ever made," said Philip Schiller, Apple's senior vice president of Worldwide Marketing. (apple.com)
- iMac with Retina 5K display delivers an amazingly immersive user experience. (apple.com)
- With a resolution of 5120 x 2880, iMac with Retina 5K display has four times more pixels than the standard 27-inch iMac and 67 percent more pixels than a 4K display. (apple.com)
- iMac with Retina 5K display uses a precisely manufactured oxide TFT-based panel to deliver vivid display brightness from corner to corner. (apple.com)
- iMac with Retina 5K display also uses highly efficient LEDs and organic passivation to improve image quality and reduce display power consumption by 30 percent, even while driving four times more pixels at the same brightness. (apple.com)
- To improve the contrast ratio, iMac with Retina 5K display uses a new photo alignment process and a compensation film to deliver blacker blacks and more vibrant colors from any viewing angle. (apple.com)
- In addition, every iMac with Retina 5K display is calibrated using three state-of-the-art spectroradiometers to ensure precise and accurate color. (apple.com)
- Not only is iMac with Retina 5K display more beautiful on the outside, it is also more powerful on the inside. (apple.com)
- Every new iMac with Retina 5K display also comes with AMD Radeon R9 M290X graphics and can be configured with AMD Radeon R9 M295X graphics, delivering up to 3.5 teraflops of computing power, the most powerful graphics ever offered on an iMac. (apple.com)
- iMac with Retina 5K display comes standard with 8GB of memory and a 1TB Fusion Drive for the first time. (apple.com)
- In addition, iMac with Retina 5K display includes two Thunderbolt 2 ports that deliver up to 20Gbps each, twice the bandwidth of the previous generation. (apple.com)
- OS X Yosemite is also engineered to take full advantage of the iMac's Retina 5K display, delivering stunning clarity across all your apps. (apple.com)
- Pricing & Availability iMac with Retina 5K display begins shipping today with a 3.5 GHz quad-core Intel Core i5 with Turbo Boost speeds up to 3.9 GHz, AMD Radeon R9 M290X graphics and a 1TB Fusion Drive for a suggested retail price of $2,499 (US). (apple.com)
- Under the initiative's terms Apple will replace display assemblies on affected Retina display-toting MacBook models free of charge, reports MacRumors . (appleinsider.com)
- Is Your Website Retina Display Ready? (webhostinggeeks.com)
- You've probably heard the term "Retina Display" here or there, but what does it mean to you? (webhostinggeeks.com)
- Get ready for the new Retina Display and a new visual experience! (webhostinggeeks.com)
- I suspect the same thing will happen with the new Retina Display and like the switch of TVs to HD and large flat screens ruining the standard 32" CRT TVs for consumers, there will be an output of cash for new hardware but there will also need to be an upgrade of the images now planted firmly on millions upon millions of web sites as well as the sites themselves. (webhostinggeeks.com)
- When Apple announced the Retina Display MacBook Pro, one of the applications with which they demonstrated it was Photoshop, but not a current release version of Photoshop. (webhostinggeeks.com)
- The current release version of CS6 opens images at the same size and the same resolution as on a non-Retina Display MacBook Pro. (webhostinggeeks.com)
- An all-new iMac will reportedly debut around October, with a high chance of sporting a Retina Display. (webhostinggeeks.com)
- Those sources also said that Apple is looking to expand its Retina Display across all product lines, which means the new iMac has a "high chance" of getting the high-resolution screen. (webhostinggeeks.com)
- Apple is reportedly pushing the Retina Display for all its products in a bid to outshine its rivals in screen resolution. (webhostinggeeks.com)
- It seems doubtful that Apple would debut a new Retina Display iMac as late as October and then push out yet another refresh next year. (webhostinggeeks.com)
- With a quad core i7 processor, Multiple Thunderbolt & USB3 ports, super high definition Retina Display powered by NVIDIA Graphics, this baby is now our hands down top choice for mobile video editing. (videoguys.com)
- The new machine packs a 15.4 inch "Retina display" which promises improved viewing angles, reduced glare, and a resolution of 2880 x 1800: four times greater than the previous MacBook Pro. (videoguys.com)
- The addition of the Retina display makes the new MacBook Pro "the world’s highest resolution notebook display" according to Apple. (videoguys.com)
- Its beautiful and large 12.9-inch Retina display has 5.6 million pixels and provides an immersive experience for content and apps. (telecomtv.com)
IMac1
- Since Retina Displays are an expensive component, other PC vendors are unlikely to jump on the higher-resolution bandwagon at this time.Beyond launching a new iMac this year, Apple will also refresh both the iMac and Mac Pro next year with brand new models, according to the sources. (webhostinggeeks.com)
Twitter1
- Now Twitter is even more vibrant and detailed on the highest resolution Mac notebooks," Ben Sandofsky, product lead, wrote about the Retina addition. (cnet.com)
Displays1
- Thursday, the company released a Mac app with simplified photo-sharing options, support for Retina displays, and 14 new languages. (cnet.com)
Lifts1
- A detached retina is when the retina lifts away from the back of the eye. (aao.org)
Apple2
- According to a report on Saturday, Apple recently instated a quality program to deal with an issue relating to Retina MacBook Pro antireflective coatings, a problem that some owners claim causes irreparable damage to their laptop screen. (appleinsider.com)
- quote name="Aybara" url="/t/189576/apple-activates-quality-program-for-retina-macbook-pro-screen-coating-issue/0_100#post_2792600"]I am so tired of the labeling every issue as (something)-Gate. (appleinsider.com)
Ready1
- Retina Ready - Envision is absolutley future proof. (themeforest.net)
Screen1
- A handful of Retina MacBook Pro owners first reported screen "staining" earlier this year , saying the problem presents itself as splotches, streaks or other surface anomalies. (appleinsider.com)
Quickly1
- But if you do not treat a detached retina, you could quickly and permanently lose your sight. (aao.org)
Features2
- To identify choroidal nevus features associated with referral to a retina or ocular oncology subspecialist. (bvsalud.org)
- Tumor features and patient demographics associated with referral to a retina or ocular oncology subspecialist were assessed. (bvsalud.org)
Include1
- Imaging modalities include optical coherence tomography (OCT), heidelberg retina tomography (HRT), and scanning laser polarimetry (SLP). (medscape.com)
Back1
- The retina is a layer of tissue in the back of your eye that senses light and sends images to your brain. (medlineplus.gov)
Vision1
- The retina does not work when it is detached, making vision blurry. (aao.org)
Problem1
- A detached retina is a serious problem. (aao.org)
Replace1
- Replace a dual microphone and its cable compatible with the MacBook Pro 15' Retina A1398 Mid 2012 to Mid 2015 model laptop. (ifixit.com)
Surgery2
Neurons2
Human retina organoid2
Organoid Challenge1
- The NEI 3-D Retina Organoid Challenge (3D ROC) is a prize competition to develop a physiologically-competent 3-D retina organoid model. (nih.gov)
Retinal9
- Retinal nerve fibers exit the eye through the optic nerve, located nasally and on the same plane as the anatomical center of the retina. (medscape.com)
- The outermost layer of the retina, the retinal pigment epithelium, is tightly attached to the choroid. (medscape.com)
- Assuming that the ocular media (cornea, anterior chamber, lens, and vitreous) are not cloudy, the living retina can be examined using a direct or with a high diopter biconvex retinal lens at the slit lamp. (medscape.com)
- In addition, the retina may be photographed using a retinal camera. (medscape.com)
- The retina, with the exception of the blood vessels coursing through it, is transparent to the examiner up to its outer layer, the retinal pigment epithelium. (medscape.com)
- The examiner sees the neurosensory retina against the background orange color of the melanin containing retinal pigment epithelium and blood-filled choroidal layer of the eye. (medscape.com)
- There is a potential space between the neurosensory retina and the retinal pigment epithelium. (medscape.com)
- In a retinal detachment, this space fills with fluid and detaches the neurosensory retina from the underlying retinal pigment epithelium. (medscape.com)
- In contrast, the light-induced decrease in retinal rhodopsin kinase may be due to the direct destructive effect of light on the retina. (nih.gov)
Diseases6
- The findings could lead to therapies to reduce vision loss from certain diseases of the retina. (nih.gov)
- In many cases, blindness and vision loss are the result of retina-damaging diseases that, if better understood, could be treated or have interventions applied to stop degeneration or provide protection to remaining viable cells. (nih.gov)
- The researchers noted that several other diseases affecting blood vessels in the retina, such as diabetic retinopathy and age-related macular degeneration, are characterized by a similar degradation of the blood-retina barrier. (nih.gov)
- Scientists can use retina organoids to study eye diseases and treatments. (nih.gov)
- In this Challenge, solution(s) should yield reproducible, retina organoid models that represent the complexity, structure, and function of the human retina and are amenable for use in either modeling diseases or high-content screening (see Evaluation Criteria & Point Allocation ). (nih.gov)
- By mapping out the evolution of vision, Noor White, Ph.D., hopes to shed light on the genetic causes of diseases that affect the retina, the part of the eye that turns light into electrical signals the brain can use to build an image of our surroundings. (nih.gov)
Organoids5
- In this Challenge, the protocols to make models used for disease modeling and drug testing are desired, and solution(s) should yield protocols that allow reproducible culture of functionally-competent retina organoids. (nih.gov)
- In this Challenge competition, NEI is seeking innovative solutions to achieve significant advances over currently available protocols to grow retina organoids. (nih.gov)
- As solvers address the evaluation criteria outlined below, they should state how and why they expect their proposed new methods or changes/additions to existing methods will improve aspects of retina organoids. (nih.gov)
- What aspects of the protocol ensure that 3-D organoids will be properly oriented and have layers recapitulating a laminated retina? (nih.gov)
- Eliminate limitations in current organoid protocols and accelerate development of 3-D retina organoids that faithfully model human tissue. (nih.gov)
Ribbon synapses2
- lower right) In prion-infected retina, prion protein (magenta) accumulates under the horseshoe-shaped ribbon synapses (green) found in photoreceptor terminals. (nih.gov)
- Our findings support a role for nyctalopin in synaptic transmission and/or synapse formation at ribbon synapses in the retina. (nih.gov)
Ophthalmoscope2
- An ophthalmoscope allows a health care provider to see through your pupil and lens to the retina. (medlineplus.gov)
- Sometimes photos or special scans of the retina can show things that the provider cannot see just by looking at the retina through the ophthalmoscope. (medlineplus.gov)
Optic nerve3
- The retina then converts these images to electric signals and sends them along the optic nerve to the brain. (medlineplus.gov)
- The average healthy retina is 250-µm thick immediately adjacent to the temporal margin of the optic nerve. (medscape.com)
- They found that the returning microglia first grew in clusters near the optic nerve, the cable-like bundle of nerve fibers that carries signals from the retina to the brain. (nih.gov)
Blood vessels2
- The retina most often looks red or orange because there are many blood vessels right behind it. (medlineplus.gov)
- The arterioles and venules of the retina are the only blood vessels whose wall can be directly examined in the living human without an incision. (medscape.com)
Regenerate3
- Similarly, adult zebrafish regenerate RGCs by reprogramming cells in the retina called Müller glia. (nih.gov)
- Other key recommendations in the report include systematic comparisons of animal models that do and do not regenerate RGCs, criteria for evaluating RGCs, and imaging techniques to assess RGC integration in the retina. (nih.gov)
- A new study showed how immune cells in the retina regenerate after being nearly eliminated in mice. (nih.gov)
Scientists2
Neural1
- Structure of the neural retina. (medlineplus.gov)
National Eye Insti1
- To test what happens in the retina after microglia have been eliminated and whether the cells can return to their normal arrangement and functions, a team led by Dr. Wai T. Wong of NIH's National Eye Institute (NEI) depleted microglia in the retinas of mice. (nih.gov)
Tissue4
- Replacing RGCs is a major challenge for the AGI," said Steven Becker, Ph.D., who coordinates the initiative-a sustained effort by the NEI to catalyze research aimed at restoring vision by regenerating the retina, the light-sensitive tissue in the back of the eye. (nih.gov)
- The retina is the light-sensitive layer of tissue at the back of the eyeball. (medlineplus.gov)
- The retina is the light-sensitive tissue that lines the inside of the eye. (medscape.com)
- The retina is delicate, light-sensitive tissue in the back of the eye, and its amacrine cells are involved in processing and conveying signals from the light-gathering photoreceptor cells to the brain's visual cortex, where the image is decoded. (nih.gov)
Specialists1
- Retina Subspecialty Day, held during this year's annual meeting of the American Academy of Ophthalmology, brought together thousands of retina specialists from across the globe. (medscape.com)
Gradually1
- Gradually, new microglia expanded outward toward the edges of the retina. (nih.gov)
Macular1
- The retina thickens to approximately 400 µm in the macular area around the fovea and thins to 150 µm in the fovea. (medscape.com)
Lens1
- Images that come through the eye's lens are focused on the retina. (medlineplus.gov)
Signals1
- Nerve fibers within the retina send electrical signals to the brain, which then interprets these signals as visual images. (medscape.com)
Protocols1
- Current protocols vary in their strengths and limitations, but none can robustly recapitulate the complexity and functionality of the retina. (nih.gov)
Similar2
- The retina functions in a manner similar to film in a camera. (medscape.com)
- A retina organoid is similar to a human retina but it's grown in a lab from stem cells. (nih.gov)
Cells12
- These lab-grown cells would then be transplanted to a patient's retina. (nih.gov)
- Cells that are too naïve may develop into unintended cell types, while those that are more mature might not easily integrate into the retina. (nih.gov)
- Images of mouse retina after being treated with a drug that nearly eliminates immune cells called microglia. (nih.gov)
- The retina is a thin layer of cells at the back of the eye. (nih.gov)
- Mixed in with these cells are microglia, specialized immune cells that help maintain the health of the retina. (nih.gov)
- When the retina is injured, microglia also work to remove unhealthy or dying cells at the injury site. (nih.gov)
- Over time, the cells re-established evenly throughout the retina. (nih.gov)
- However, retina biology researchers have developed methods to grow 3-D retina models in vitro from induced pluripotent stem cells (iPSC) and embryonic stem cells (ESC). (nih.gov)
- Cell Types: What aspects of protocol ensure that all five neuronal retina cell types (photoreceptors, bipolar cells, ganglion cells, horizontal cells, and amacrine cells) will be produced on included? (nih.gov)
- Within the eye, the main cells infected by prions are the light-detecting photoreceptors known as cones and rods, both located in the retina. (nih.gov)
- But these dots and lines are actually cells in the retina of a goldfish. (nih.gov)
- NIH-funded researchers at the University of Utah used a set of tools called Computational Molecular Phenotyping (CMP) to take a snapshot of the amacrine cells in the retina. (nih.gov)
Study2
Complexity1
- Currently, retina culture models do not capture the complexity of the human retina. (nih.gov)
Function2
- Researchers have suggested that a deficiency of P5C may interfere with the function of the retina. (nih.gov)
- The goal of the Challenge is to transform innovative ideas into concrete concepts to develop new in vitro 3-D human retina models that recapitulate the organization and function of the human retina. (nih.gov)
Brain1
- The changes in the retina were correlated with changes in the brain related to Alzheimer's disease and cognitive decline. (nih.gov)
Research2
Cell types2
Focus1
- The optical elements within the eye focus an image onto the retina of the eye, initiating a series of chemical and electrical events within the retina. (medscape.com)
Vision loss1
- Gyrate atrophy of the choroid and retina, which is often shortened to gyrate atrophy, is an inherited disorder characterized by progressive vision loss. (nih.gov)
Layer2
- The retina is the innermost layer. (medscape.com)
- Within the retina, strong nyctalopin immunoreactivity is present in the outer plexiform layer, the site of the photoreceptor to bipolar cell synapses. (nih.gov)
Mouse1
- Further work showed that a molecule called CX3CL1 played a significant role in microglial repopulation in the mouse retina. (nih.gov)
Days2
Center2
- The center of the optic disc is located 4.5 mm to 5 mm nasal to the anatomical center of the retina. (medscape.com)
- The center of the retina provides the greatest resolving power of the eye. (medscape.com)
Method1
- The team used a novel method to visually track microglial movements in the retina. (nih.gov)